References
- Borchard F, Ehms H, Miller B, Wienbeck M, Strohmayer G, Brunner G. Morphology of granulomatous mucosal alterations of the upper gastrointestinal tract in Crohn’s disease. Verh Dtsch Ges Pathol 1980;64:262–8.
- Wright CL, Ridell RH. Histology of the duodenum and stomach in Crohn’s disease. Mod Pathol 1996;9:68A.
- Oberhuber G, Püspök A, Ostereicher C, Novacek G, Zauner C, Burghuber M, et al. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn’s disease. Gastroenterology 1997;112:698–706.
- Meining A, Bayerdörffer E, Bästlein E, Raudis N, Thiede C, Cyrus B, et al. Focal inflammatory infiltrations in gastric biopsy specimens are suggestive of Crohn’s disease. Scand J Gastroenterol 1997;32:229–37.
- Sipponen P, Stolte M. Clinical impacts of routine antral and corpus biopsies. Endoscopy 1997;29:671–8.
- Dixon MF, Genta RM, Yardley JH, Correa P, the participants in the International Workshop on the Histopathology of Gastritis, Houston 1994.. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996;120:1161–81.
- Halme L, Kärkkäinen P, Rautelin H, Kosunen TU, Sipponen P. High frequency of helicobacter negative gastritis in patients with Crohn’s disease. Gut 1996;38:379–83.
- Prantera C, Zannoni F, Scribano ML, Berto E, Andreoli A, Kohn A, et al. An antibiotic regimen for the treatment of active Crohn’s disease. a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 1996; 91:328–32.
- Ursing B, Kamme G. Metronidazole for Crohn’s disease. Lancet 1975;1:775–7.
- Gilat T. Metronidazole in Crohn’s disease. Gastroenterology 1882;83:702–4.